Ushbu ish iqtibos qilgan ishlar

28 ta ish

Ish: Mannosylated engineered trichosanthin-legumain protein vaccine hydrogel for breast cancer immunotherapy

1. Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature

   Yingzhi Chen, Meng Zhang, Hongyue Jin +6

   Maqola20167 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.193286

2. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

   Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard +7

   Maqola20075 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.198076

3. Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy

   Aihua Wu, Yingzhi Chen, Hairui Wang +8

   Maqola20213 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.106279

4. A Sixty-Year Research and Development of Trichosanthin, a Ribosome-Inactivating Protein

   Jiaqi Lü, Kam‐Bo Wong, Pang‐Chui Shaw

   Sharh maqola20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.111814

5. The role of tumor-associated macrophage in breast cancer biology.

   Junjeong Choi, Jones Gyamfi, Haerin Jang +1

   Sharh maqola20183 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.198078

6. Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer

   Xiaofen Lu, Tengteng Meng

   Maqola20192 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.051887

7. Depletion of Tumor-Associated Macrophages Slows the Growth of Chemically Induced Mouse Lung Adenocarcinomas

   Jason M. Fritz, Meredith A. Tennis, David J. Orlicky +9

   Maqola20142 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.055406

8. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

   Katrina Bauer, Monica Brown, Rosemary D. Cress +2

   Maqola20072 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.198067

9. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

   Graziella Solinas, Giovanni Germano, Alberto Mantovani +1

   Sharh maqola20092 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.198075

10. Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment

    Yisi Tang, Wufa Fan, Guihua Chen +8

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198084

11. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198068

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198069

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198070

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198071

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198072

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198073

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198074

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198077

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198079

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198080

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198081

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198082

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198083

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198085

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.198086